Pharma Journalist, Author at Pharma Journalist - Page 850 of 877

Mylan Completes Acquisition of Cold-EEZE Brand

Vanda and UCSF Announce License Agreement for CFTR Activators and Inhibitors

Perrigo Completes Divestiture Of Tysabri Royalty Stream For Up To $2.85 Billion

Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Bruno Farmaceutici S.p.A.

Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline

Perrigo Completes Divestiture Of Tysabri Royalty Stream For Up To $2.85 Billion

Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Bruno Farmaceutici S.p.A.

Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline

Newron Presents Results of Its Phase IIa Study with Evenamide in Patients with Schizophrenia

CHMP provides positive opinion for EU label update for Novo Nordisk’s Tresiba